IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026)

IM Cannabis' (IMCC) quarterly Depreciation & Amortization (CF) came in at $26980.6 in Q1 2026, down 15.84% year-on-year from $32058.2 in Q1 2025, and down 64.5% quarter-over-quarter from $76011.1 in Q4 2025.

IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

IM Cannabis' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $26980.6 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 15.84% year-over-year to $26980.6 in Q1 2026; TTM through Mar 2026 was $223209.5, a 23.24% increase from a year earlier, with the FY2025 full-year figure at $228033.4, down 11.05% from the prior year.
  • Depreciation & Amortization (CF) fell to $26980.6 in Q1 2026 per IMCC's latest filing, from $76011.1 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $819475.5 in Q1 2022 and bottomed at $13601.1 in Q4 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $77703.7 (2024), against an average of $194641.5.
  • Across the five-year window, Depreciation & Amortization (CF) sank 84.29% in 2023 and soared 458.86% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $378665.3 in 2022, then slumped by 80.6% to $73453.6 in 2023, then plunged by 81.48% to $13601.1 in 2024, then surged by 458.86% to $76011.1 in 2025, then tumbled by 64.5% to $26980.6 in 2026.
  • Per Business Quant, the three latest IMCC Depreciation & Amortization (CF) figures stand at $26980.6 (Q1 2026), $76011.1 (Q4 2025), and $61037.3 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn 26,980.61

Historic Data

Download Data
DateValue
Mar 31, 2026 26,980.61
Mar 31, 2026 26,980.61
Dec 31, 2025 76,011.15
Dec 31, 2025 76,011.15
Sep 30, 2025 61,037.34
Sep 30, 2025 61,037.34
Jun 30, 2025 59,180.42
Jun 30, 2025 59,180.42
Mar 31, 2025 32,058.16
Mar 31, 2025 32,058.16
Dec 31, 2024 13,601.13
Dec 31, 2024 13,601.13
Sep 30, 2024 77,703.66
Sep 30, 2024 77,703.66
Jun 30, 2024 57,760.10
Jun 30, 2024 57,760.10
Mar 31, 2024 109,090.64
Mar 31, 2024 109,090.64
Dec 31, 2023 73,453.55
Dec 31, 2023 73,453.55